See every side of every news story

Published 4 days ago • loading... • Updated 4 days ago

Myosin Therapeutics Publishes Two Foundational Studies in the Journal Cell Highlighting a Novel Approach to Treating Cancer and Brain Disorders

Summary by Queens Chronicle

JUPITER, Fla., July 7, 2025 /PRNewswire/ -- Myosin Therapeutics, a clinical-stage biotechnology company advancing first-in-class therapies targeting molecular motor proteins, announced the publication of two major papers in the journal Cell that establish non-muscle myosin II (NMII) as a druggable…

10 Articles

10 Articles

All

Left

3

Center

3

Right

1

Chatham Star Tribune

+9 Reposted by 9 other sources

Myosin Therapeutics Publishes Two Foundational Studies in the Journal Cell Highlighting a Novel Approach to Treating Cancer and Brain Disorders

JUPITER, Fla., July 7, 2025 /PRNewswire/ -- Myosin Therapeutics, a clinical-stage biotechnology company advancing first-in-class therapies targeting molecular motor proteins, announced the publication of two major papers in the journal Cell that establish non-muscle myosin II (NMII) as a druggable…

4 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources10

Leaning Left3Leaning Right1Center3Last Updated4 days agoBias Distribution

43% Left, 43% Center

Bias Distribution

43% of the sources lean Left, 43% of the sources are Center

43% Center

Untracked bias

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

World News broke the news in United States 5 days ago on Monday, July 7, 2025.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.